Company profile
Vectura Group plc is a product development company focused on the development of a range of inhaled therapies principally for the treatment of respiratory diseases.
Vectura has eight products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, some of which have been licensed to major pharmaceutical companies. The Company seeks to develop certain programmes further through development to optimise value through licensing at a later stage. Vectura also offers its formulation and inhalation technologies to other pharmaceutical companies on a licensing basis where this complements Vectura’s business strategy.
Vectura is based in the UK, with headquarters and development operations in Chippenham, Wiltshire, further laboratories in Nottingham, and device development in Cambridge.
Vectura's shares trade on the London Stock Exchange under the symbol VEC.
